This study analyzed the correlation with clinical outcomes in patients with several adverse genotypes, and the results suggest that the cumulative influence by multiple genetic variants within the TGF-β signaling pathways could improve the prediction accuracy for survival among patients with NSCLC after RT. Here, TGFB1 is linked to non-small cell lung carcinoma.